Laserfiche WebLink
<br />') <br /> <br />o <br /> <br />) Determination, without regard to whether the advice was relied upon in making the Adverse <br />Benefit Determination. <br /> <br />16.07.07 The appeal shall provide that the Health Professional engaged for purposes ofa consultation <br />in Subsection 16.07.05 shall be an individual who is neither an individual who was <br />consulted in connection with the initial Adverse Benefit Determination that is the subject of <br />the appeal, nor the subordinate of any such individual. <br /> <br />16.07.08 In the case of an Urgent Care Claim, there shall be an expedited review process pursuant to <br />which: <br /> <br />a) Request for an expedited appeal of an Adverse Benefit Determination may be submitted <br />orally or in writing by the Claimant; and <br /> <br />b) All necessary information, including AvMed's benefit determination on review, shall be <br />transmitted between AvMed and the Claimant by telephone, facsimile, or other <br />available similarly expeditious methods. <br /> <br />16.08 Manner and content of appeal notification. AvMed shall provide a Claimant with written or <br />electronic notification ofAvMed's benefit determination upon review. <br /> <br />16.08.0] In the case of an Adverse Benefit Determination, the notification shall set forth, in a manner <br />calculated to be understood by the Claimant, all of the following, as appropriate: <br /> <br />a) The specific reasons for the Adverse Benefit Determination. <br /> <br />b) Reference to the specific Plan provisions on which the Adverse Benefit Determination <br />is based. <br /> <br />c) A statement that the Clairnant is entitled to receive, upon request, and free of charge, <br />reasonable access to, and copies of any Relevant Documents. <br /> <br />) <br /> <br />d) A statement describing any voluntary appeal procedures offered by AvMed and the <br />Claimant's right to obtain the information about such procedures and a statement of the <br />Claimant's right to bring an action under ERISA Section 502(a) when applicable. <br /> <br />e) If an internal rule, guideline, protocol, or other similar criterion was relied upon in <br />making tbe Adverse Benefit Determination, either the specific rule, guideline, protocol, <br />or other similar criterion or a statement that such rule, guideline, protocol, or other <br />similar criterion was relied upon in rnaking the Adverse Benefit Determination and that <br />a copy shall be provided free of charge.to the Claimant upon request. <br /> <br />f) If the Adverse Benefit Determination is based on whether the treatment or service is <br />experimental and/or investigational or not Medically Necessary, either an explanation <br />of the scientific or clinical judgment for the determination, applying the terms of the <br />Plan to the Claimant's rnedical circumstances, or a statement that such explanation shall <br />be provided free of charge upon request. <br /> <br />XVII. MISCELLANEOUS <br /> <br />17.0 I Applicability of law. The provisions of this Contract shall be deemed to have been modified by the <br />parties, and shall be interpreted, so as to comply with the Jaws and regulations of the State of Florida <br />and the United States. <br /> <br />44 <br /> <br />A V -0100-2009 <br />MP-5319 (]0/09) <br />